Paul R. Solomon, PhD
Dr. Paul Solomon is a founder and the Director of the Boston Center for Memory in Newton, MA. He specializes in Clinical Neuropsychology and Clinical Neuroscience. Dr. Solomon is also an Investigator of the Boston University Alzheimer's Disease Center, Boston University School of Medicine.
Dr. Solomon was appointed Professor Emeritus of Psychology and Neuroscience at Williams College the summer of 2018. He was the founding Chairman of the Neuroscience Program at Williams College in Williamstown, MA. Dr. Solomon taught in the areas of neuropsychology and behavioral neuroscience and conducted research on the neurobiology of memory disorders.
He had a fully funded laboratory at Williams College for 20 years. He was particularly interested in the memory deficits associated with Alzheimer’s disease. During this time he became interested in investigating memory disorders in a clinical setting and providing diagnostic and clinical care services to patients with neurodegenerative conditions.
Dr. Solomon and Dr. William Pendelbury (a neurologist at the University of Vermont Medical Center) founded the Memory Clinic (Clinical Neurosciences Research Associates) in Bennington, VT in 1987. Dr. Solomon served as the President and Clinical Director of the Memory Clinic from 1987-2017. He also served as the first Director of Training for the the Memory Clinic as part of the Southwestern Vermont Psychology Consortium. He transitioned his time from the Memory Clinic in 2012 when he founded the Boston Center for Memory in Newton, MA.
Dr. Solomon was a lead investigator on the clinical trials for Cognex, the first drug approved for the treatment of Alzheimer’s disease in 1994. He was an author on the paper published in the Journal of the American Medical Association (JAMA) that served as the basis for the FDA approval of the drug. Since that time he has served as a principle investigator on more than 150+ clinical trials in Alzheimer’s disease and served as an investigator on the trials that led to the FDA approval of the 4 approved medications available to treat Alzheimer's disease (Aricept/donepezil, Galantamine/razadyne, Exelon/rivastigmine, Namenda/memantine). Additionally, he was an investigator of the trials that led to the approval of the first PET amyloid scan ligand (Amyvid/florbetapir).
Dr. Solomon has received numerous awards including a Distinguished Teaching Award from the University of Massachusetts, a National Research Service Award from the National Institutes of Health, and a National Needs Postdoctoral Fellowship from the National Science Foundation, and two clinical research awards from the American Association of Family Physicians. He has been elected as a Fellow of the American Association for the Advancement of Science, the American Psychological Association and the American Psychological Society. He is listed in Who’s Who in America, American Men and Women of Science, Who’s Who in Education, and Who’s Who in Frontier Science and Technology.
Dr. Solomon has served on the Editorial Board of several journals and serves as an external reviewer for numerous journals and granting agencies. He has served on the advisory boards of the Northeastern New York Alzheimer's Association and the MA/NH Chapter Alzheimer's Association. He has delivered more than 500 lectures nationally and internationally widely at colleges and universities on age-related memory disorders and at medical centers and hospitals on the diagnosis and treatment of Alzheimer’s disease.
Dr. Solomon has also appeared frequently to discuss pharmacotherapy for Alzheimer’s disease on national television including The Today Show, Good Morning America, The CBS Morning Show, and CBS, ABC, and NBC Evening News. His work on screening for Alzheimer ’s disease has been featured on Dateline NBC, NPR, Newsweek, New York Times, Forbes, and the Larry King Radio Show. Dr. Solomon developed two screening instruments for Alzheimer's disease, the 7 Minute Screen, and the Alzheimer's Disease Caregiver Questionnaire.
Dr. Solomon received his Ph.D. in Psychology from the University of Massachusetts Amherst. He was a postdoctoral fellow in the Laboratory of Richard F. Thompson in Department of Psychobiology at the University of California at Irvine. He is the author of 10 books including most recently, Memory Loss, Alzheimer's Disease, and Dementia, 2nd Edition, A Practical Guide for Clinicians. He has also contributed chapters to 20 edited volumes, and has co-authored and presented more than 200 research papers. His work has been published in Science, Scientific American, Journal of the American Medical Association, and Lancet. He has delivered more than 500 invited colloquia, symposia, grand rounds, lectures, and presentations. He has been the recipient of research grants from the National Science Foundation, The National Institute on Aging, The National Institute of Mental Health, The United States Environmental Protection Agency, as well as private foundations and pharmaceutical research divisions.
Dr. Solomon is a licensed clinical neuropsychologist in Massachusetts and Vermont.